Treatment in a stroke unit and risk factor control reduce recurrent stroke risk
Cerebrovascular Diseases Extra
Abstract
Introduction: The risk factor control is an important predictor of risk of stroke recurrence. The attributable fraction which estimates the excess risk among the exposed stroke survivors has not been studied previously. We studied the attributable fraction for stroke recurrence in consecutive incident cases of recurrent stroke. Methods: A case control study with incident cases of recurrent stroke and controls matched for age and post stroke period was done. Structured interview was done to collect data on sociodemographic variables, lifestyle and medication adherence. The risk factors, treatment of index stroke and outcome were collected. Logistic regression analysis was done to find out the factors associated with stroke recurrence. Attributable fraction and average attributable fraction were calculated. Results: Among the 103 matched pairs, more than 70% were rural residents. Male gender (OR 2.59; 95% CI 1.05-6.42), presence of depression (OR 8.67 95% CI 2.80- 26.84), memory problem (OR 10.12 95% CI 2.48- 41.34), uncontrolled diabetes (OR 3.19 95% CI 1.42- 7.19), cardioembolic stroke (OR 4.45 95% CI 1.12- 17.62) and index stroke not being treated in stroke unit (OR 6.60 95% CI 2.86- 15.23 were associated with increased risk of stroke recurrence. The maximum average attributable fraction for stroke recurrence risk was attributed to index stroke not being treated in stroke unit and uncontrolled diabetes. Conclusion: The index stroke treated in a comprehensive stroke care unit and control of risk factors can reduce recurrent stroke risk among stroke survivors. This population attributable risk is important in planning secondary stroke prevention strategies.
The Author(s). Published by S. Karger AG, Basel
Article / Publication Details
Received: January 25, 2022
Accepted: May 13, 2022
Published online: July 06, 2022
Issue release date: May - August
eISSN: 1664-5456 (Online)
For additional information: https://www.karger.com/CEE
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
留言 (0)